446: Maternal pregnancy complications associated with intrahepatic cholestasis of pregnancy in a population-based cohort

Puljic, Anela; Kim, Elissa; Esakoff, Tania F.; LaCoursiere, D. Yvette; Shaffer, Brian L; Caughey, Aaron B.

doi:10.1016/j.ajog.2014.10.492

Search citation statements

Order By: Relevance

Paper Sections

Select...

Discussion1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2020

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…14 ICP affected pregnant women are at increased risk of developing PE, GDM, chorioamnionitis, PPh, CS. 15 These women may be associated with subsequent development of hepatobiliary cancer, DM, thyroid disease, Cohn's disease and other immune mediated disorders. 16 UDCA has emerged as the most promising first line treatment for ICP.…”

Section: Discussionmentioning

confidence: 99%

A rare case of early onset intrahepatic cholestasis of pregnancy

Saraswathi

Joshi

Ganta

2020

Int J Reprod Contracept Obstet Gynecol

View full text Add to dashboard Cite

Intrahepatic cholestasis of pregnancy (ICP) is an important complication of pregnancy requiring increased surveillance by the obstetricians due to its increased foetal morbidity and mortality in the form of preterm birth, foetal distress, RDS including sudden IUD and stillbirth. The incidence of ICP is increasing due to IVF and routine administration of progesterone in early pregnancy. ICP usually presents in late second and third trimester. Here authors are presenting a case of early onset ICP (14 weeks) which developed in an IVF conception.

show abstract

Section: Discussionmentioning

confidence: 99%